CHRISTINE WELLS-WONSLEY: Open Payments
NPI 1225504616 · OCEAN SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 59 payments from 10 companies in 2025. Trend: 2023 $975 · 2024 $877 · 2025 $922
Food & beverage: $922
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $298 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $196 |
| Lilly USA, LLC | 9 | $113 |
| PFIZER INC. | 5 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $62 |
| Amgen Inc. | 3 | $50 |
| Novo Nordisk Inc | 2 | $38 |
| Exact Sciences Corporation | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Antares Pharma, Inc. | 1 | $23 |
Products named: TRINTELLIX, VRAYLAR, QULIPTA, MOUNJARO, NURTEC ODT, CAPLYTA, EVENITY, FARXIGA.
Industry payments across MS — which companies pay providers there.
